In one paragraphArticle in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
María Valeria RazoriInstitute of Experimental Physiology (IFISE), Department of Physiological Sciences, Faculty of Biochemical and Pharmaceutical Sciences, National University of Rosario, Rosario 2000, Argentina.
Geraldine L HillotteInstitute of Experimental Physiology (IFISE), Department of Physiological Sciences, Faculty of Biochemical and Pharmaceutical Sciences, National University of Rosario, Rosario 2000, Argentina.
Pamela L MartínInstitute of Experimental Physiology (IFISE), Department of Physiological Sciences, Faculty of Biochemical and Pharmaceutical Sciences, National University of Rosario, Rosario 2000, Argentina.ORCID 0000-0001-9051-6294 Ismael R BarossoInstitute of Experimental Physiology (IFISE), Department of Physiological Sciences, Faculty of Biochemical and Pharmaceutical Sciences, National University of Rosario, Rosario 2000, Argentina.ORCID 0000-0001-7400-8118 Cecilia L BasiglioInstitute of Experimental Physiology (IFISE), Department of Physiological Sciences, Faculty of Biochemical and Pharmaceutical Sciences, National University of Rosario, Rosario 2000, Argentina.
María Laura RuizInstitute of Experimental Physiology (IFISE), Department of Physiological Sciences, Faculty of Biochemical and Pharmaceutical Sciences, National University of Rosario, Rosario 2000, Argentina.ORCID 0000-0003-3693-5679 Marcelo G RomaInstitute of Experimental Physiology (IFISE), Department of Physiological Sciences, Faculty of Biochemical and Pharmaceutical Sciences, National University of Rosario, Rosario 2000, Argentina.ORCID 0000-0002-1660-9801 Funding
Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación PICT 2019-1965Consejo Nacional de Investigaciones Científicas y Técnicas PIP 2022-2024-11220210100552COIntercept Pharmaceuticals (United States) Investigator-Initiated Study ITT-15030
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
bile saltsBsephepatocellular transporterslipopolysaccharide-induced cholestasismultidrug resistance-associated protein 2obeticholic acid
Identifiers
PMID41304731
PMCPMC12655158
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390